Free Trial

Stoke Therapeutics (STOK) Insider Trading & Ownership

Stoke Therapeutics logo
$32.18 -0.46 (-1.39%)
As of 01:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$9.81M
Get STOK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STOK Insider Buying and Selling by Quarter

Stoke Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/19/2026Sell1,461$29.99$43,815.39  
3/18/2026Sell6,686$31.34$209,539.24  
3/18/2026Sell1,931$31.34$60,517.54  
3/18/2026
Jonathan Allan
Jonathan Allan
General Counsel
Sell4,628$31.34$145,041.52  
3/18/2026Sell2,382$31.34$74,651.88  
3/17/2026Sell6,164$33.01$203,473.64  
3/17/2026Sell1,781$33.01$58,790.81  
3/17/2026
Jonathan Allan
Jonathan Allan
General Counsel
Sell4,267$33.01$140,853.67  
3/17/2026Sell2,196$33.01$72,489.96  
3/13/2026Sell605$36.80$22,264.00  
3/10/2026Sell33,243$39.74$1,321,076.82  
3/10/2026Sell4,355$40.00$174,200.00  
12/8/2025Sell13,430$32.27$433,386.10  
12/8/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell3,978$32.28$128,409.84  
12/5/2025Sell3,662$31.34$114,767.08  
12/5/2025Sell8,548$31.32$267,723.36  
12/5/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell8,785$31.29$274,882.65  
12/4/2025Sell1,696$30.87$52,355.52  
12/4/2025Sell6,453$30.87$199,204.11  
12/4/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell1,018$30.87$31,425.66  
12/3/2025Sell2,014$30.65$61,729.10  
12/3/2025Sell1,070$30.65$32,795.50  
12/3/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell2,292$30.65$70,249.80  
12/2/2025Sell2,006$29.78$59,738.68  
12/2/2025Sell1,066$29.78$31,745.48  
12/2/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell2,284$29.78$68,017.52  
11/14/2025Sell40,472$26.98$1,091,934.56  
11/3/2025Sell5,931$25.72$152,545.32  
10/8/2025Sell25,000$30.00$750,000.00  
10/3/2025Sell42,461$25.09$1,065,346.49  
10/3/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell10,000$25.07$250,700.00  
9/3/2025Sell45,996$20.13$925,899.48  
9/3/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell6,345$20.07$127,344.15  
9/2/2025Sell5,501$19.87$109,304.87  
9/2/2025Sell14,860$20.14$299,280.40  
9/2/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell14,922$20.14$300,529.08  
8/29/2025Sell1,029$20.00$20,580.00  
8/29/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell850$20.00$17,000.00  
8/13/2025
Jonathan Allan
Jonathan Allan
General Counsel
Sell13,712$15.00$205,680.00  
8/1/2025Sell4,504$12.82$57,741.28  
6/3/2025Sell6,471$10.03$64,904.13  
6/2/2025Sell1,745$10.00$17,450.00  
(Data available from 1/1/2013 forward)

STOK Insider Trading Activity - Frequently Asked Questions

The list of insiders at Stoke Therapeutics includes Adrian R Krainer, Arthur A Levin, Arthur Tzianabos, Barry Ticho, Edward M Md Kaye, Jason Hoitt, Jonathan Allan, Skorpios Trust, Stephen J Tulipano, and Thomas Leggett. Learn more on insiders at STOK.

9.50% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings.

The following insiders have sold STOK shares in the last 24 months: Adrian R Krainer ($2,413,011.38), Arthur A Levin ($22,264.00), Arthur Tzianabos ($174,200.00), Barry Ticho ($1,651,047.77), Edward M Md Kaye ($4,282,975.60), Jason Hoitt ($119,308.35), Jonathan Allan ($2,089,689.25), Skorpios Trust ($27,221,875.00), and Thomas Leggett ($147,141.84).

Insiders have sold a total of 2,394,681 Stoke Therapeutics shares in the last 24 months for a total of $38,121,513.19 sold.



This page (NASDAQ:STOK) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners